by Gemma Escarré,
Alta Life Sciences, the fund led by Guy Nohra, Montserrat Vendrell, Miguel Valls and Scott Moonly and a CataloniaBio & HealthTech member, has led a €3-million round of investment in Mediktor. The round also included Dutch fund Castel Capital and French Naos Capital Partners.
Mediktor is a symptom assessment software launched as a free app in 2014. Over this time, it has done more than 2 million evaluations of symptoms in 150 countries and created a database that can recognise roughly 750 diseases, covering 90% of the cases seen in emergency and primary care. Recently, Mediktor has collaborated with Hospital Clinic.
With this injection, Mediktor now has its sights set on the United States. The company has a team of 20 at its headquarters in Barcelona's Pier01 and has just opened a sales office in New York.
Cristian Pascual, co-founder and CEO of Mediktor, will be a speaker at the upcoming Lessons Learned Digital health: revolutionising the sector being held by CataloniaBio & HealthTech on 29 October.